Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: Results from the randomized phase iII children's oncology group Trial AAML0531

Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi, Lillian Sung, Robert B. Gerbing, Susana C. Raimondi, Betsy A. Hirsch, Samir B. Kahwash, Amy Heerema-McKenney, Laura Winter, Kathleen Glick, Stella M. Davies, Patti Byron, Franklin O. Smith, Richard Aplenc

Research output: Contribution to journalArticlepeer-review

241 Scopus citations
Original languageEnglish (US)
Pages (from-to)3021-3032
Number of pages12
JournalJournal of Clinical Oncology
Issue number27
StatePublished - Sep 20 2014

Cite this